Antibacterial Products Global Market Report 2024

Antibacterial products are materials designed to either destroy bacteria or inhibit their growth and reproductive capabilities. These compounds are commonly present in detergents, health and skincare products, and household cleansers, serving to disinfect surfaces and eliminate potentially harmful bacteria.

The primary types of antibacterial products include body wash, body moisturizer, hand cream and lotion, hand soaps, hand sanitizers, facial cleansers, and facial masks. Body wash antibacterial products are formulated to effectively eliminate germs on the surface of hands or body. Available in liquid or bar form, these soaps combine detergents or detergent additives with antimicrobial ingredients. The various product forms, including bars, powder, and liquid, are accessible through various distribution channels such as hypermarkets, supermarkets, pharmacy and drug stores, specialty stores, online platforms, and others.

The antibacterial products market research report is one of a series of new reports that provides antibacterial products market statistics, including antibacterial products industry global market size, regional shares, competitors with an antibacterial products market share, detailed antibacterial products market segments, market trends and opportunities, and any further data you may need to thrive in the antibacterial products industry. This antibacterial products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antibacterial products market size has grown strongly in recent years. It will grow from $42.45 billion in 2023 to $44.59 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. The surge in growth during the historical period can be attributed to heightened awareness of hygiene, advancements in healthcare infrastructure, regulatory support, shifts in consumer behavior and preferences, and the rise in travel activities.

The antibacterial products market size is expected to see strong growth in the next few years. It will grow to $56.62 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The anticipated growth in the forecast period is linked to the increase in infectious diseases, a growing demand for personal care products, the aging population, the rise of e-commerce and online sales, and the emergence of new markets. Key trends expected in this period involve the adoption of nanotechnology, the preference for natural and organic products, the incorporation of antibacterial fabrics, the integration of AI and machine learning, and a focus on collaborative research and development.

The growth of the antibacterial products market is anticipated to be propelled by an increased demand for germ protection items. Germ protection products encompass substances that actively reduce and prevent bacterial infections, including triclosan hand sanitizers, disinfectants, and other agents promoting bacterial resistance. These products fall within the category of antibacterial goods, serving to control skin infections. Notably, owing to the COVID-19 pandemic, India's Council of Scientific and Industrial Research (CSIR) laboratories produced and distributed 50,000 liters of hand sanitizers and disinfectants, benefitting over 100,000 individuals across diverse societal segments. Furthermore, hand sanitizer sales soared in Italy by 1,807% and by 1,400% in the United States, underscoring the heightened demand for germ-protection products driving the growth of the antibacterial products market.

The increase in skin infections is anticipated to bolster the growth of the antibacterial products market. Skin infections caused by bacteria affecting the skin and, in severe instances, deeper tissues, result in skin infections, with conditions like cellulitis characterized by redness, swelling, and pain. Antibacterial products are instrumental in managing skin infections attributed to bacteria, often necessitating the use of antibiotics for acute cases. A report from the National Library of Medicine and the Centre for Biomedical Informatics in August 2023 revealed over 14 million cases of bacterial skin infections, including cellulitis, occurring annually in the United States. This surge in skin infections serves as a driver for the growth of the antibacterial products market.

A significant trend shaping the antibacterial products market is the emergence of new product innovations. Major companies within this sector are focused on launching novel products to maintain their market standing. For instance, in March 2021, ITC, an India-based manufacturer of fast-moving consumer goods and sanitary products, introduced Savlon moisturizing sanitizer, featuring a unique formulation containing five moisturizing ingredients. This non-drying and non-sticky product effectively eliminates 99.9% of germs without the use of soap or water, while the inclusion of five moisturizers ensures skin remains soft, supple, and hydrated. This marked the first sanitizer incorporating moisturizing elements, showcasing the trend of innovation in antibacterial products.

Prominent companies within the antibacterial products market are spearheading innovative technologies, including the development of antibacterial and antiviral-coated glass. This groundbreaking technology aims to curtail the proliferation of bacteria and viruses on surfaces. The efficacy of this technology operates in both light and dark environments, offering durable and transparent glass surfaces. For instance, in June 2021, NSG Group, a Japan-based glass manufacturing company, introduced antibacterial and antiviral-coated glass, responding to the heightened interest in antiviral materials amid the global pandemic. The innovative glass is based on NSG Group’s distinctive sol-gel technology known as NSG Purity, which renders it a desirable option for areas requiring cleanliness and hygienic surfaces that people frequently touch. The applications of this glass extend beyond covering smart devices like smartphones and tablets to encompass a wide array of equipment, including touch screens on cash registers, ATMs, medical devices, elevators, and household appliances, making it suitable for use in public spaces and homes.

In February 2022, Binnopharm Group, a Russia-based pharmaceutical manufacturing entity, acquired the Ciprolet and Levolet antibacterial medicine brands from Dr. Reddy’s Laboratories for an undisclosed sum. This strategic acquisition serves to bolster Binnopharm Group's production capabilities in the antibacterial sector while also enhancing their manufacturing capacity in Russia. Dr. Reddy’s Laboratories, an India-based company specializing in the production of antibacterial products, medicines, and related items, transferred ownership of these specific antibacterial medicine brands, marking a significant move in the expansion of Binnopharm Group's pharmaceutical portfolio.

Major companies operating in the antibacterial products market include Reckitt Benckiser Group PLC, Unilever PLC, Gojo Industries Inc., Himalaya Drug Company Pvt Ltd., Sebapharma GmbH & Co. KG, Bielenda Pioneered, Colgate-Palmolive Co., Henkel Corporation, Johnson & Johnson, Farouk Systems Inc., Rockline Industries, Tufco LP, Guardpack, Nice-Pak Products Inc., Usp Life Sciences, Betco Corporation, Carroll Company, Xttrium Laboratories, Kutol Products Company, Whiteley Corporation, CarrollCLEAN, Elyptol, Deb Group Ltd., Eka Chemicals AB, Christeyns, Saraya Co. Ltd., Ruhof Corporation, Microban International, Decon Labs, Metrex Research

Asia-Pacific was the largest region in the antibacterial products market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibacterial products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the antibacterial products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The antibacterial products market consists of sales of antivirals, antibiotics and antifungals. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.